{"id":"W3003995118","doi":"10.1002/ehf2.12555","title":"Highlights in Heart Failure","year":2019,"lang":"en","type":"review","venue":"ESC Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Hazard ratio; Ejection fraction; Clinical endpoint; Sacubitril; Dapagliflozin; Enalapril; Cardiology; Decompensation; Valsartan; Ranolazine; Placebo; Confidence interval; Hyperkalemia; Adverse effect; Randomized controlled trial; Blood pressure; Type 2 diabetes; Diabetes mellitus; Endocrinology; Angiotensin-converting enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004198905,0.00107897,0.001110957,0.001563824,0.001448562,0.007075779,0.00165983,0.005383429,0.07494222],"category_scores_gemma":[0.009779294,0.0003131322,0.0008116432,0.001663169,0.001534819,0.004230623,0.003294791,0.008924723,0.02934753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002230696,"about_ca_system_score_gemma":0.004661088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001704983,"about_ca_topic_score_gemma":0.002773072,"domain_scores_codex":[0.9976948,0.0005923721,0.000218191,0.0003479066,0.0007749373,0.0003716736],"domain_scores_gemma":[0.9924976,0.001612711,0.0003948681,0.0003315769,0.002529782,0.002633435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000560841,0.00002539258,0.000264656,0.0007430539,0.00001733338,0.000131247,0.0001200377,0.00002759915,0.0001433796,0.00759864,0.8212397,0.169633],"study_design_scores_gemma":[0.00001769218,0.00003230984,0.0004868076,0.0006683638,0.0000119865,0.0001656138,0.00009833548,0.00001676254,0.00003058331,0.002306822,0.996159,0.00000584283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.0007166451,0.2207944,0.001258659,0.376507,0.3141135,0.0001093636,0.0009642617,0.0003363834,0.08519978],"genre_scores_gemma":[0.01074591,0.2187069,0.002076784,0.1946476,0.4694634,0.0002233605,0.001678985,0.0002487716,0.1022083],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.07494222,"threshold_uncertainty_score":0.2507067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.030302811380363,"score_gpt":0.3088280836124762,"score_spread":0.2785252722321132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}